Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Louis Januzzi Jr., M.D.

Co-Author

This page shows the publications co-authored by James Januzzi and Muthiah Vaduganathan.
Connection Strength

4.540
  1. Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin. J Am Coll Cardiol. 2022 02 08; 79(5):432-444.
    View in: PubMed
    Score: 0.986
  2. Preventing and Treating Heart Failure with Sodium-Glucose Co-Transporter 2 Inhibitors. Am J Cardiol. 2019 12 15; 124 Suppl 1:S20-S27.
    View in: PubMed
    Score: 0.849
  3. Cost and Value in Contemporary Heart Failure Clinical Guidance Documents. JACC Heart Fail. 2022 Jan; 10(1):1-11.
    View in: PubMed
    Score: 0.242
  4. Patient Characteristics and Clinical Outcomes of Type 1 Versus Type 2 Myocardial Infarction. J Am Coll Cardiol. 2021 02 23; 77(7):848-857.
    View in: PubMed
    Score: 0.231
  5. Natriuretic Peptides as Inclusion Criteria in Clinical Trials: A JACC: Heart Failure Position Paper. JACC Heart Fail. 2020 May; 8(5):347-358.
    View in: PubMed
    Score: 0.216
  6. Contemporary Trends in Prescription of Dipeptidyl Peptidase-4 Inhibitors in the Context of US Food and Drug Administration Warnings of Heart Failure Risk. Am J Cardiol. 2020 05 15; 125(10):1577-1581.
    View in: PubMed
    Score: 0.216
  7. De novo heart failure: where the journey begins. Eur J Heart Fail. 2019 10; 21(10):1245-1247.
    View in: PubMed
    Score: 0.208
  8. Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists. J Am Coll Cardiol. 2019 04 02; 73(12):1596-1598.
    View in: PubMed
    Score: 0.202
  9. Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling. J Am Coll Cardiol. 2018 12 25; 72(25):3370-3372.
    View in: PubMed
    Score: 0.198
  10. Type 2 Myocardial Infarction and the Hospital Readmission Reduction Program. J Am Coll Cardiol. 2018 09 04; 72(10):1166-1170.
    View in: PubMed
    Score: 0.194
  11. Type 2 Myocardial Infarction-Diagnosis, Prognosis, and Treatment. JAMA. 2018 Aug 07; 320(5):433-434.
    View in: PubMed
    Score: 0.193
  12. Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes. Curr Diab Rep. 2021 09 27; 21(10):41.
    View in: PubMed
    Score: 0.060
  13. Hospitalizations and Outcomes of T1MI Observed Before and After the Introduction of MI Subtype Codes. J Am Coll Cardiol. 2021 09 21; 78(12):1242-1253.
    View in: PubMed
    Score: 0.060
  14. The Intersection of Type 2 Myocardial Infarction and Heart Failure. J Am Heart Assoc. 2021 09 07; 10(17):e020849.
    View in: PubMed
    Score: 0.060
  15. Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel. J Am Coll Cardiol. 2020 11 17; 76(20):2368-2378.
    View in: PubMed
    Score: 0.057
  16. Cardiologist Evaluation of Patients With Type 2 Myocardial Infarction. Circ Cardiovasc Qual Outcomes. 2021 01; 14(1):e007440.
    View in: PubMed
    Score: 0.056
  17. Home-Time After Discharge Among Patients With Type 2 Myocardial Infarction. J Am Heart Assoc. 2020 05 18; 9(10):e015978.
    View in: PubMed
    Score: 0.055
  18. Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues. Circulation. 2019 12 17; 140(25):2108-2118.
    View in: PubMed
    Score: 0.053
  19. Application of the GRACE, TIMI, and TARRACO Risk Scores in Type 2 Myocardial Infarction. J Am Coll Cardiol. 2020 01 28; 75(3):344-345.
    View in: PubMed
    Score: 0.053
  20. Sex Differences in Patient Characteristics, Treatment Strategies, and Outcomes for Type 2 Myocardial Infarction. J Am Coll Cardiol. 2019 06 25; 73(24):3230-3232.
    View in: PubMed
    Score: 0.051
  21. Misclassification of Myocardial Injury as Myocardial Infarction: Implications for Assessing Outcomes in Value-Based Programs. JAMA Cardiol. 2019 05 01; 4(5):460-464.
    View in: PubMed
    Score: 0.051
  22. Wake Forest University long-term follow-up of type 2 myocardial infarction: The Wake-Up T2MI Registry. Clin Cardiol. 2019 Jun; 42(6):592-604.
    View in: PubMed
    Score: 0.051
  23. Association of the New Peer Group-Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program. JAMA Netw Open. 2019 04 05; 2(4):e192987.
    View in: PubMed
    Score: 0.051
  24. Left Ventricular Thrombus: Contemporary Etiologies, Treatment Strategies, and Outcomes. J Am Coll Cardiol. 2019 04 23; 73(15):2007-2009.
    View in: PubMed
    Score: 0.050
  25. Underutilization of Cardiac Rehabilitation for Type 2 Myocardial Infarction. J Am Coll Cardiol. 2019 04 23; 73(15):2005-2007.
    View in: PubMed
    Score: 0.050
  26. Left Ventricular Thrombus After Acute Myocardial Infarction: Screening, Prevention, and Treatment. JAMA Cardiol. 2018 07 01; 3(7):642-649.
    View in: PubMed
    Score: 0.048
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.